BRAF and thyroid gland carcinoma: In this study, we provide genetic characterization of locally advanced T4 well differentiated thyroid cancer and demonstrate that the majority (19/25, 76%) are driven by BRAF V600E mutation and 12 (48%) also harbor co-existent TERT promoter mutations.